文献速递前列腺癌

2012年美国预防服务工作组声明实施后前列腺特异性抗原检测预筛查讨论的现状

The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement.
PubMed 文献 · Urology · 2017-03-16

该横断面研究利用2012年和2014年行为危险因素监测系统调查,分析217,053名男性中前列腺特异性抗原(PSA)预筛查讨论质量的变化。结果显示37%的男性仅被告知优势,30%被告知优势与劣势;2014年较2012年,未讨论任何优势或劣势即接受PSA检测的可能性显著增加,且讨论质量在种族/民族、教育、收入和保险状态方面存在差异并扩大。

要点

  • 37%的男性仅被告知PSA筛查优势,30%被告知优势与劣势。
  • 2014年男性未讨论任何优势或劣势即接受PSA检测的可能性显著高于2012年。
  • 讨论质量差异与西班牙裔、低教育、低收入及无保险相关。

核心结论

  • 关于PSA检测优势与劣势的全面预筛查讨论对前列腺癌筛查的知情决策至关重要。
  • 预筛查讨论质量在种族/民族、教育、收入和保险状态方面存在差异,且这些差异在2012年至2014年间变得更显著。
  • 需要进一步调查以揭示这些差异背后的具体原因。

研究设计与样本

  • 横断面研究,使用2012年和2014年行为危险因素监测系统调查数据。
  • 分析样本包括217,053名男性,根据调查年份分类。
  • 预筛查讨论质量定义为仅讨论优势、仅讨论劣势、讨论优势和劣势或两者均未讨论。

主要发现

  • 在217,053名男性中,37%仅被告知PSA筛查优势,30%被告知优势和劣势。
  • 被告知两者均未讨论的男性更可能是西班牙裔、未高中毕业、低收入和无保险。
  • 控制协变量后,2014年男性未讨论任何优势或劣势即接受PSA检测的可能性显著高于2012年男性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步调查以揭示这些差异背后的具体原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if the quality of prescreening discussions has changed following release of the United States Preventive Services Task Force statement against prostate cancer screening. METHODS: This cross-sectional study used the 2012 and 2014 Behavioral Risk Factor Surveillance System surveys. Respondents were categorized based on the year in which they responded to the Behavioral Risk Factor Surveillance System Survey. Quality of prescreening discussion was operationalized as having discussed only advantages, only disadvantages, both advantages and disadvantages, or neither. Race/ethnicity, education level, income, insurance status, and having a prostate-specific antigen (PSA) level actually drawn after prescreening counseling served as confounders in our multivariate analysis. RESULTS: Among 217,053 men in the analytic sample, 37% were told about only advantages of PSA screening compared to 30% of men who were advised about both advantages and disadvantages. Men who were told about neither advantages nor disadvantages were more likely to be Hispanic, not graduate high school, have low income, and not have insurance. Controlling for covariates, men in 2014 were significantly more likely to have undergone PSA testing without having discussed either advantages or disadvantages than men in 2012. CONCLUSION: Comprehensive prescreening discussions about advantages and disadvantages of PSA testing are critical to informed decision making about prostate cancer screening. Disparities not only exist with regard to the quality of prescreening discussions that patients receive from their providers prior to PSA testing across categories of race/ethnicity, education, income, and insurance status, but these disparities became more substantial between 2012 and 2014. Further investigation is warranted to elicit more specific reasons behind these variations.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Turini GA, Gjelsvik A, Renzulli JF, et al. The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement. Urology. 2017. PMID: 28322897. doi:10.1016/j.urology.2016.12.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。